---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293388133.md"
description: "Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 1.01% to $8.98 on Tuesday, underperforming the broader market and key competitors like Vanda Pharmaceuticals and Fortress Biotech. The stock remains significantly below its 52-week high of $20.56. Trading volume was notably lower than the 50-day average."
datetime: "2026-07-21T21:19:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293388133.md)
  - [en](https://longbridge.com/en/news/293388133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293388133.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 1.01% to $8.98 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.29% to 25,837.21 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.

Corbus Pharmaceuticals Holdings Inc. closed 56.32% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 3.01% to $5.48, Fortress Biotech Inc. (FBIO) rose 6.01% to $3.53, and Viking Therapeutics Inc. (VKTX) rose 4.32% to $37.95.

Trading volume (80,808) remained 455,049 below its 50-day average volume of 535,857.

Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-21-26 1719ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [JAZZ: Record growth, new launches, and AI-driven strategies fuel rare disease expansion and raised outlook](https://longbridge.com/en/news/298625568.md)
- [Apple is reportedly working on iPhone game controllers](https://longbridge.com/en/news/298837739.md)
- [Journey Medical CEO Maraoui to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298359762.md)
- [Quantum Biopharma amends Form 6-K to add exhibit to F-3 registration statement](https://longbridge.com/en/news/298348186.md)
- [These 2 biotech stocks hit record highs today – what’s driving the rallies?](https://longbridge.com/en/news/298354082.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**